Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Robert Van-Nostrand Insider Profile
4 Followers
Robert Van-Nostrand, Director at Intra-Cellular Therapies, holds 7.57K shares in Intra-Cellular Therapies (Ticker: ITCI), holds ― shares in SELLAS Life Sciences Group (Ticker: SLS), holds 0.00 shares in Achillion Pharmaceuticals (Ticker: ACHN).
Robert Van-Nostrand Intra-Cellular Therapies (ITCI)Director
Intra-Cellular Therapies (ITCI)
Director
Ranked #10,658 out of 78,624 Corporate Insiders
Profitable Transactions
2 out of 5 Profitable Transactions
Average Return
+32.30%
Average return per transaction
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that Robert Van-Nostrand holds in companies
Most Profitable Insider Trade
Stock:
Achillion Pharmaceuticals
(ACHN)
(ACHN)
Rating:Informative Buy
Date:Dec 18, 2018 - Dec 18, 2019
Return:+216.90%
The most profitable trade made by Robert Van-Nostrand
Robert Van-Nostrand's Trading History
Intra-Cellular Therapies
Jul 02, 2020
Director
Uninformative Buy
7.06K
$189.02K
SELLAS Life Sciences Group
―
Director
―
―
Yield10 Bioscience
Jul 05, 2017
Director
Uninformative Buy
―
$217.50K
Achillion Pharmaceuticals
Jan 29, 2020
―
Uninformative Sell
252.00K
$0.00
Enumeral Biomedical
Jan 05, 2017
―
Uninformative Buy
―
$45.45
List of latest transactions for each holding click on a transaction to see Robert Van-Nostrand's performance on stock
You May Also Like
Robert Van-Nostrand insider profile FAQ
What is the percentage of profitable transactions made by Robert Van-Nostrand?
The percentage of profitable transactions made by Robert Van-Nostrand is 40%.
What is the average return per transaction made by Robert Van-Nostrand?
The average return per transaction made by Robert Van-Nostrand is 32.30%.
What stocks does Robert Van-Nostrand hold?
Robert Van-Nostrand holds: ITCI, SLS, YTEN, ACHN, ENUMQ stocks.
What was Robert Van-Nostrand’s latest transaction?
Robert Van-Nostrand latest transaction was an Uninformative Buy of $7.06K.
What was Robert Van-Nostrand's most profitable transaction?
Robert Van-Nostrand’s most profitable transaction was an Informative Buy of ACHN stock on December 18, 2018. The return on the trade was 216.90%.
What is Robert Van-Nostrand's role in Intra-Cellular Therapies?
Robert Van-Nostrand's role in Intra-Cellular Therapies is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.